Last reviewed · How we verify
NCT05111873
Effects of Multimodal Treatment of Headache in a Day Clinic Service
trial testing multimodal treatment in Headache Disorders in 50 participants. Status unknown.
30 April 2022
Quick facts
| Lead sponsor | University Medicine Greifswald |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 15 February 2021 |
| Primary completion | 30 April 2022 |
| Estimated completion | 30 May 2022 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- multimodal treatment — full drug profile →
Conditions studied
- Headache Disorders — all drugs for Headache Disorders →
Sponsor
University Medicine Greifswald
Who can join
18 and older, any sex, with Headache Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The observational study aims to investigate the effects of a multimodal treatment program for headache patients in a day clinic service. The setting provides one week of treatment including a combination of medical consultation, physiotherapy, psychological therapy, occupational therapy, progressive muscle relaxation and disease specific education. Outcome measures are the disease-specific impact on daily activities, general quality of life, psychological impact and headache frequency. Moreover, the study sought to identify parameters that best predict efficacy of the intervention. Therefore, standardized questionnaires are established in three points in time, to evaluate the pre- and post-treatment status.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05111873
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Headache Disorders
Currently open trials in the same condition.
- NCT07419607 — MIGRAFIT: Evaluating a Group Therapy Program Combining Physical Activity, Progressive Muscle Relaxation and Psychoeducat · NA · recruiting
- NCT07268768 — PERSONOLOGICAL STRUCTURE, COGNITIVE FUNCTIONS AND CENTRAL SENSITIZATION IN HEADACHE · recruiting
- NCT07307508 — Efficacy of Scalp Block in Managing Post Subarachnoid Hemorrhage Headache in Critically Ill Patients. A Single Centre Ra · NA · recruiting
- NCT06894121 — Comparing Unilateral and Bilateral Proximal GONPRF in Migraine Treatment · NA · active not recruiting
- NCT06041997 — Smartphone Use Restriction as Treatment of Primary Headache · NA · recruiting
Other University Medicine Greifswald trials
Trials by the same sponsor.
- NCT06796374 — A Comparison of Fisetin Kinetics in Young and Old Adults · NA · recruiting
- NCT06970171 — Acceptance of Mandibular Advancement Devices · NA · not yet recruiting
- NCT06939608 — Kinetics of Yohimbine in Humans to Explore Sex and CYP2D6 Genotype Interactions · NA · completed
- NCT06273241 — Impact of Food Intake on Berberine Kinetics · NA · completed
- NCT06249451 — Staphylococcus Aureus Bacteraemia (SAB)-Support-Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05111873 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Medicine Greifswald
- Last refreshed: 8 November 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05111873.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing